Drug Trial Radar · NCT07055516
Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus
Last checked: Nov 19, 2026Latest source record: Sep 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
176
Actual
Start
May 8, 2025
Primary completion
May 27, 2026
Study completion May 27, 2026
Sponsor
- Lead sponsor
- NodThera Ltd. (a Rezera company)Industry
- Sponsor type
- Industry
- First posted
- Jul 9, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NT-0796 as an Adjunct to a Reduced Calorie Diet and Increased Physical Activity in Obese Participants With/Without Type 2 Diabetes over a 6 months treatment period.
Conditions
- Obesity and Type 2 Diabetes
Interventions
NT-0796Drug
Orally administered capsules
PlaceboDrug
Orally administered capsules
Primary outcomes
What the sponsor says the trial is designed to measure.
- Ratio Change in hsCRP in participants with obesity and without T2DM hsCRPTime frame: Baseline to Week 24
- Change in body weight in participants with obesity with and without T2DMTime frame: Baseline to Week 24
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Investigative site
Mesa, Arizona
Investigative site
Los Angeles, California
Investigative site
Cooper City, Florida
Investigative Site
Hialeah, Florida
Investigative Site
Jacksonville, Florida
Investigative Site
Miami, Florida
Investigative Site
Port Orange, Florida
Investigative Sites
Marrero, Louisiana
Investigative Site
Columbus, Ohio
Investigative Site
Dallas, Texas
Investigative Site
Manassas, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.